Back to Results

Ampio Pharm (AMPE)

Ampio Pharmaceuticals, Inc. is a healthcare company focused on biopharmaceutical development. The company is working on therapies for osteoarthritis of the knee in the United States, including OA-201, a small-molecule formulation being developed for knee pain associated with the condition. Ampio Pharmaceuticals is organized as common stock and is quoted on OTC Markets under the symbol AMPE. The company is based in Englewood, Colorado.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Market Cap
OTC-AMPE	Not available	Not available	Not available	Fair	0.0%	207.884 K

Smart Snapshot

Stock Overview

A fast read of the company and market metrics currently supported by the latest data.

Company Profile

Sector

Healthcare

Industry

Pharmaceuticals

Quality & Risk

Financial Health

Fair

Valuation • Fair Value

Ampio Pharm (OTC-AMPE) Fair Value by Valuation Model

No usable valuation estimate is currently available for Ampio Pharm (OTC-AMPE); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Ampio Pharm (OTC-AMPE). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Ampio Pharm (OTC-AMPE)

Review the profitability and growth indicators currently supported by the latest data.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Ampio Pharm (OTC-AMPE) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Ampio Pharm (OTC-AMPE)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Ampio Pharm (OTC-AMPE). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Ampio Pharm (OTC-AMPE)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Ampio Pharm (OTC-AMPE). No upcoming dividend amount or event date is currently available.

Stock Forecast • Technical Outlook

Ampio Pharm (OTC-AMPE) Stock Forecast & Technical Outlook

Review Ampio Pharm (OTC-AMPE) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: daily • daily

Neutral

The daily technical read for Ampio Pharm (OTC-AMPE) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: weekly • weekly

Neutral

The weekly technical read for Ampio Pharm (OTC-AMPE) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: monthly • monthly

Sell

The monthly technical read for Ampio Pharm (OTC-AMPE) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Ampio Pharm (OTC-AMPE)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy

Consolidated analyst recommendation mix

Hold

Based on the available recommendation mix, Ampio Pharm (OTC-AMPE) has a Hold consensus, with 0 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 0

Hold 1

Sell 0

FAQ • Fast Investor Answers

Ampio Pharm (OTC-AMPE) Stock FAQ

Data-supported answers about Ampio Pharm (OTC-AMPE), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value

Not available

No reliable estimate from the currently supported inputs

Financial Health

Fair

Current financial-health read

A reliable fair value estimate is not currently available for Ampio Pharm (OTC-AMPE). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Ampio Pharm (OTC-AMPE) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Ampio Pharm (OTC-AMPE).

The current market capitalization listed for Ampio Pharm is 207.884 K.

The ticker symbol for Ampio Pharm is OTC-AMPE, and the stock is listed on OTC Markets.

Ampio Pharm (OTC-AMPE) is listed on OTC Markets.